ArticleFrontiers in medical technology2026
Development of remote radar based vital sign acquisition for emergency department patient triage.
Article in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To enable remote acquisition of patients' vital signs, ELTA Systems Ltd. developed a Radar remote vital signs acquisition system (TAMAR). The system identifies chest and neck respiratiory movements and pulse wave movements, enabling quantification of respiratory and pulse rates. The validation process of the TAMAR system is reported. Methods: A multicenter, prospective observational study was performed, enrolling low acuity patients who presented to 3 Emergency Departments. Patients provided consent and had their pulse and respiratory rates simultaneously measured by the TAMAR radar system and a traditional monitor (Mindray BeneVision N15). Vital signs were recorded continuously by both systems for 150 s, and later compared using Bland-Altman statistical analysis. Results: Between May and September 2021 we enrolled 315 patients. Measurements were calculated in 181/259 (70%) patients for Heart Rate (HR), and in 191/252 patients (76%) for Respiratory Rate (RR). For RR, the upper level of agreement (LOA) was 1.0, and the lower LOA was 1.6 respirations per minute. For HR, the upper level of agreement was 4.7, and the lower LOA was 3.5 beats per minute. All of these were well below the predetermined acceptable LOA of +/- 10 percent of the reference monitor rate. Discussion: The vital signs acquired by the TAMAR system, based on 90-second average measurements, are statistically adequate compared to traditional monitors, suggesting that TAMAR may replace traditional monitors for patients' triage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.